Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Myeloablative Chemotherapy With Stem Cell Rescue for Rare Poor-Prognosis Cancers

NCT00141765 is registered in ClinicalTrials.gov with University of Michigan Rogel Cancer Center as lead sponsor.

NCT NCT00141765
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00141765 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Myeloablative Chemotherapy With Stem Cell Rescue for Rare Poor-Prognosis Cancers
Lead sponsor
University of Michigan Rogel Cancer Center
Phase
Phase 2
Overall status
Completed
Start date
January 31, 1997
Completion date
February 28, 2010
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain tumor, recurrent, carcinoma, round cell, fibrosarcoma, nasopharyngeal cancer, wilms tumor